Hospira Recalls Ketorolac Tromethamine Injections Due to Temperature Abuse
Hospira Inc. is recalling 100 vials of Ketorolac Tromethamine Injection due to uncontrolled temperature excursions during transit. The product was limited to one shipment to a distributor.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II, which typically involves a situation that could cause temporary or medically reversible adverse health consequences. The hazard is temperature abuse, which is a low-risk contamination or quality issue without reported illness.
Plain-English summary
Hospira Inc. is recalling 100 vials of Ketorolac Tromethamine Injection, USP, 60 mg (30 mg/mL), 2 mL Single-dose Fliptop Vial. The recall is due to temperature abuse, as the products experienced uncontrolled temperature excursions during transit.
The affected product is identified by Lot # 34-540-DK with an expiration date of 1OCT2015. The distribution was limited to one shipment to The Harvard Drug Group in Livonia, MI. These lots remained within the control of the distributor and were not further distributed.
Consumers and healthcare providers should check their inventory for this specific lot number. If found, the product should be returned to the distributor or the manufacturer for credit.
The recalled product
- Product
- KETOROLAC TROMETHAMINE (KETOROLAC TROMETHAMINE)
- Brand
- KETOROLAC TROMETHAMINE
- Manufacturer
- Hospira Inc.
- Category
- Drug — Injection
- Hazard
- Affected units
- 100
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (4)
- One shipment of Lot #: 34-540-DK
- Exp 1OCT2015 to The Harvard Drug Group
- Livonia
- MI
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 4 recalled by Hospira Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 4 products in this recall →Related recalls
Same brand · KETOROLAC TROMETHAMINE
- HighKetorolac injection vials recalled after glass particulate found in product
FDA (Drugs) · 2025-10-29
- HighKetorolac ophthalmic solution recalled over sterility assurance and bottle sealing concerns
FDA (Drugs) · 2025-10-08
- SevereKetorolac Tromethamine Ophthalmic Solution Recalled for Sterility Risk
FDA (Drugs) · 2025-07-02
- HighInjectable ketorolac tromethamine recalled nationwide for potential cross-contamination
FDA (Drugs) · 2022-08-24
- SevereFresenius Kabi Recalls Ketorolac Tromethamine Injection Due to Particulate Matter
FDA (Drugs) · 2021-02-03
Same manufacturer · Hospira Inc.
See all →- CriticalHospira Recalls Dextrose Injection Syringes Due to Human Hair Particulate
FDA (Drugs) · 2017-05-31
- ModerateHospira Recalls Minibore Extension Sets Due to Solvent Occlusion
FDA (Devices) · 2017-01-18
- LowHospira Recalls Lidocaine and Dextrose Injection for Stability Failures
FDA (Drugs) · 2016-12-14
- SevereHospira Recalls Fentanyl Citrate Injection Ampules Due to Broken Tips
FDA (Drugs) · 2016-11-30
- HighHospira Symbiq Infusion Pump Recall for White Screen Safety Shutdown
FDA (Devices) · 2016-11-16
Same hazard · temperature abuse
See all →- ModerateGemcitabine Injection Recalled Due to Temperature Storage Abuse
FDA (Drugs) · 2026-07-08
- ModerateGarland Fresh peeled garlic recalled over Clostridium botulinum contamination risk
FDA (Food) · 2026-05-13
- ModerateChristopher Ranch peeled garlic recalled over Clostridium botulinum contamination risk
FDA (Food) · 2026-05-13
- SevereCrab Cakes Sold to Food Service Recalled for Botulism Risk
FDA (Food) · 2026-04-15
- CriticalUDENYCA syringes recalled after cartons were stored at room temperature
FDA (Drugs) · 2026-02-18